Peter L. Slavin and David F. Torchiana on the science and importance of Lyme disease.
In most cases, antibiotics do the trick. But when they don’t, symptoms can be devastating. New research aims to discover why.
Attitudes towards hormone therapy have shifted toward a more nuanced approach.
Where do scientific prizes fit in the research funding landscape?
“Smart bubble wrap” could help lead to better prosthetics.
It’s disappointing when seemingly groundbreaking studied can’t be repeated. But it’s happening a lot.
Peter L. Slavin and David F. Torchiana on the value of reproducing research.
Sharply pared budgets could kill the Framingham Heart Study—after 50 years of astonishing research breakthroughs.
The Supreme Court ruled on whether genes can be patented. But the answers aren’t crystal clear.
No Articles Found.
Stay on the frontiers of medicine